• iCAD (Nashua, New Hampshire) reported the availability of the TotalLook MammoAdvantage system which converts prior mammography films to digital images for comparative review on a single digital review workstation. This new version of iCAD’s state-of-the-art film digitizing solution offers improved image quality, enhanced image customization options and workflow efficiency features. TotalLook MammoAdvantage’s new DigitalLook and PremiumLook image outputs closely match digital mammography images offering enhanced tissue visualization, higher contrast and better edge definition to improve comparative reading. TotalLook MammoAdvantage’s unique software offers configurable image resolution settings that display the digitized images at the same resolution as the digital mammography images, enabling the digitized and newly acquired digital images to be displayed at the same size. The software provides flexible DICOM connectivity solutions for seamless integration with leading review workstations, PACS and RIS systems. iCAD makes Computer-Aided Detection (CAD) solutions for the early detection of cancer.

• Immunicon (Huntingdon Valley, Pennsylvania) said the FDA has cleared the CellSearch Circulating Tumor Cell (CTC) Kit as an aid in the monitoring of patients with metastatic prostate cancer. A sample of the patient’s blood is processed with the CellSearch Kit using the CellTracks System to capture and count CTCs. This clearance represents another expansion to claims for the kit, which is now cleared for three of the four most prevalent cancers. According to the American Cancer Society, prostate cancer claims approximately 27,000 lives each year, the vast majority of which are a result of recurrent metastatic disease. Metastatic prostate cancer occurs when tumor cells spread to other locations in the body and grow. Immunicon makes cell- and molecular-based human diagnostic and life science research products with an initial focus on cancer disease management.

• The Home Respiratory Care Group of Respironics’ (Murrysville, Pennsylvania) reported availability of EverFlo Q, a five-liter stationary oxygen concentrator and newest member of the company’s Freedom Series of oxygen therapy products. The 31-pound EverFlo Q oxygen concentrator is designed to provide ultra-quiet oxygen therapy to patients while reducing provider costs such as maintenance, unscheduled patient calls and visits, and shipping and storage. These non-equipment-related expenses account for 72% of the costs of providing home oxygen therapy to oxygen patients, the company said. The EverFlo Q stationary concentrator produces a typical sound level of just 40 decibels. The Sleep and Home Respiratory Group makes products for the management of sleep disorders and chronic respiratory problems.

• Rubbermaid Medical Solutions (RMS; Huntersville, North Carolina) reported the launch of a new M38 Mobile computer cart line featuring a powered computer cart, pre-wired computer cart and non-powered computer cart. The new line adds to the overall RMS product offering, which also includes medication carts, wall mounted work stations, and transfer and exchange carts. Key features for the M38 cart include compact 17” x 17” base contoured to 14.5” wide at the center; fully adjustable keyboard tray including 6” of height range, 180 swivel and -15 to +10 tilt; work surface has a 16” range of adjustable height with a total keyboard range of 22;” and multiple storage options including side bins, a wire basket and a drawer with keyless entry. Rubbermaid Medical makes mobile carts and mobile computing solutions for healthcare facilities.

• SynergEyes (San Diego) has launched a hybrid contact lens designed for those who need further vision correction after undergoing refractive vision surgery. SynergEyes PS (post-surgical) is also designed for people who have experienced some type of corneal trauma or suffer from certain degenerative vision conditions. The contact lenses combine two materials — a rigid gas permeable center with a soft lens outer skirt. The hybrid design bonds a hard and soft contact lens together, resulting in a vision correction option the company said provides “crisp, clear vision for surgically altered corneas in a comfortable, healthy contact lens.”